(Total Views: 254)
Posted On: 03/12/2019 2:35:22 PM
Post# of 86220
Maybe an advocate for our cause? New acting commissioner of FDA...We’ll see... UNVC!
https://www.cnbc.com/2019/03/12/national-canc...ioner.html
“Norman Sharpless (Ned), current director of the National Cancer Institute (NCI) is another contender for Gottlieb’s position. In the 1980’s Ned coauthored articles that discussed marijuana's euphorigenic properties in rats. Today, the NCI’s website admits, “cannabis has been used for medicinal purposes for thousands of years.. promoted for reported analgesic, sedative, anti-inflammatory, antispasmodic, and anticonvulsant effects.” Their website even states that physicians were the principal opponents of the Marihuana Tax Act 1937 which made cannabis more difficult to procure. As many cancer patients are users of medicinal marijuana and NCI’s website seems to recognize the benefits of both THC and CBD, Ned Sharpless would likely clear the way for healthcare providers to research and develop cannabis medication.”
https://www.reddit.com/r/wallstreetbets/comme...means_for/
https://www.cnbc.com/2019/03/12/national-canc...ioner.html
“Norman Sharpless (Ned), current director of the National Cancer Institute (NCI) is another contender for Gottlieb’s position. In the 1980’s Ned coauthored articles that discussed marijuana's euphorigenic properties in rats. Today, the NCI’s website admits, “cannabis has been used for medicinal purposes for thousands of years.. promoted for reported analgesic, sedative, anti-inflammatory, antispasmodic, and anticonvulsant effects.” Their website even states that physicians were the principal opponents of the Marihuana Tax Act 1937 which made cannabis more difficult to procure. As many cancer patients are users of medicinal marijuana and NCI’s website seems to recognize the benefits of both THC and CBD, Ned Sharpless would likely clear the way for healthcare providers to research and develop cannabis medication.”
https://www.reddit.com/r/wallstreetbets/comme...means_for/
(0)
(0)Scroll down for more posts ▼
